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The effect of chronotherapy on delirium in critical care- a systematic review  
Delirium is prevalent within intensive care and high dependency units (critical care), 
affecting 1 in 5 high dependency patients and 4 in 5 mechanically ventilated patients with 
clear causation between critical illness and incidence of delirium (Page and Ely, 2011). 
However, despite its incidence, preventative measures are limited and treatment 
interventions focus on symptom control once delirium has manifested (Barroso and den 
Brinker, 2013).  
Delirium is a syndrome characterised by acutely altered mental state, cognitive impairment 
and fluctuations throughout the course of the day (American Psychiatric Association, 2013). 
Delirium has serious short and long term consequences for patient outcome independent of 
severity of illness, including fewer days alive without mechanical ventilation, increased 6-
month mortality, prolonged hospital stay, and higher incidence of cognitive impairment on 
discharge (Ely, 2004). Acute confusional states can develop and patients can go on to 
experience post traumatic stress disorder (PTSD).  Long-term studies have shown that 
prolonged episodes of delirium increase risk of long-term cognitive impairment at 3 months 
(p=0.03) and 12 months (p=0.02) post-discharge (Girard et al., 2010), with impairment of 
quality of life (Gunther et al., 2012). 
Although the pathogenesis is not fully understood, delirium is known to be caused by 
neuronal dysfunction secondary to systemic disorders and multiple coexisting risk factors 
(Madrid-Navarro et al., 2015). Predisposing risk factors include older age, high APACHE-2 
score, mechanical ventilation and metabolic acidosis (Zaal et al., 2015). Studies have also 
linked the development of delirium to precipitating risk factors such as abnormal levels of 
melatonin and loss of circadian rhythms (Meagher et al., 2007; Bellapart and Boots, 2012; 
Fitzgerald et al., 2013; Madrid-Navarro et al., 2015; Oldham et al., 2016).   
The artificial critical care environment and iatrogenic sleep disturbance are linked to 
circadian disruption with likely development of delirium (Wenham and Pittard, 2009; 
Delaney et al., 2015). Attention has turned to the potential benefits of chronotherapy, 
defined as “modifying circadian rhythms with therapeutic intent” (Oldham et al., 2016, p. 
209). This incorporates interventions which modulate the environment (light, noise control) 
as well as drugs which influence circadian rhythm.  
Chronotherapeutic options such as bright light therapy (BLT) and dynamic light applications 
(DLA) are well proven within psychiatry to treat seasonal depression (Koyama et al., 1999; 
Madrid-Navarro et al., 2015). Bright light therapy is the use of lighting up to 10,000 lux for at 
least two hours/ day, whereas dynamic light application is the periodic dimming of lighting 
from, for example, 1700 lux to 300 lux.  Exogenous melatonin and melatonergic agents have 
also been shown to improve sleep in the critical care setting, as well as reduce incidence of 
delirium in acutely ill elderly patients (Shilo et al., 2000; Bourne et al., 2008; Sultan, 2010; 
Al-Aama et al., 2011; Oldham et al., 2016). Delirium guidelines (NICE, 2010) recommend 
multicomponent nonpharmacological interventions (MNI), such as the use of ear plugs, to 
modify external environment cues, promote the sleep-wake cycle and entrain the circadian 
rhythm (Madrid-Navarro et al., 2015). The use of drugs that may enhance circadian rhythm 
are not within the NICE (2010) guidelines.  
Research question: Can chronotherapy reduce the prevalence of delirium in adult patients 
in critical care? 
Aim: To understand whether implementation of chronotherapy within the critical care 
setting can reduce the prevalence of delirium. 
Objectives:   
• To identify specific research that has evaluated the effect of chronotherapy 
interventions 




A systematic search of recent research (2006- 2016) was undertaken using the databases 
Academic Search Complete, CINAHL Plus with Full Text, E-Journals, MEDLINE Complete, 
PsycARTICLES and PsycINFO. This was supplemented by a hand search of relevant articles 
and journals. The key search terms, which incorporated MeSH terms, were chronotherap* 
OR chronoenhancement OR light therapy OR environmental light* OR environmental 
factor* OR dynamic light* OR melaton* AND deliri* OR psychos?s OR acute confusional 
state AND critical care OR ITU OR ICU OR intensive therapy OR intensive care OR critically ill.  
Selection criteria and screening process 
During the selection process, inclusion/ exclusion criteria were applied: 
Inclusion criteria            
 Primary research investigating chronotherapy interventions and their effects on 
delirium in adults in critical care. 
 Quantitative study design 
 English language 
 Adult patients (18+ years) 
 Critical care settings 
 Articles published since 2006 
Exclusion criteria 
 Research with a different focus  
 Secondary research/ literature reviews 
 Paediatric studies 
Identified studies were screened for relevance using a three stage process ensuring a 
systematic approach. Firstly the title was reviewed. Secondly, the abstract was reviewed to 
ensure the inclusion/ exclusion criteria were adhered to. The final stage of screening 
involved reviewing the studies in full to ensure all fulfilled the search criteria. Both authors 
undertook the screening process independently and then agreed on the eligibility of the 
studies for inclusion. 
 
Data extraction and quality appraisal 
Both authors extracted the data, such as methodology, sample sizes and statistics (mean 
scores, standard deviation, p values) from each included study, using a standardised 
extraction form. Outcomes for delirium such as CAM- ICU scores were extracted as well as 
other data recorded during the study which could lead to delirium (such as hours of sleep). 
The eligible studies were appraised using either the critical appraisal skills programme 
(CASP) randomised controlled trial (RCT) checklist or the CASP cohort study checklist 
depending on research methodology/ design. This allowed the authors to appraise the 
quality of the studies in relation to, for example, appropriateness of study design and 





The initial search returned 99 results from the databases used. A hand search of relevant 
critical care journals identified three further studies. After applying the exclusion criteria 
and removing duplicates, 49 articles were left. 31 studies were then excluded following title 
and abstract scrutiny as they did not meet the inclusion criteria. The full text of the 
remaining 18 articles were read and a further 12 excluded due to having the wrong focus for 
example, delirium and circadian disruption caused by weaning from mechanical ventilation. 
This resulted in six studies being identified from the main search and a PRISMA flow chart 
was developed (figure 1).  
Five studies were randomised controlled trials (RCT) and one study used a cohort-based 
design with historical control for ‘pre-intervention’ data (table 1).  Two of the studies were 
conducted in Europe and four were conducted in East Asia. All studies measuring delirium 
used validated delirium assessment tools: CAM-ICU, DRS-R98 and J-NCS. Interventions 
included dynamic light therapy, bright light therapy, Ramelteon and multicomponent non 
pharmacologic interventions such as noise reduction, use of music, use of eye shades and 
patient orientation  
Following data extraction, common themes were inductively identified through a narrative 
review approach (Aveyard, 2014). Themes were identified by the two authors 
independently, then compared and refined.  Four key themes were found: 
1) delirium prevalence and duration;  
2) circadian rhythm: arrhythmia and entrainment;  
3) sleep efficiency and disturbance;   
4) other therapeutic effects.    
Delirium Prevalence and duration 
All studies measured the effect of different chronotherapeutic interventions on the 
incidence of delirium within critical care. Hatta et al. (2014) found delirium occurred in 1/33 
(3%) of patients taking the melatonergic agonist Ramelteon vs. 11/34 (32%) in the control 
group. Likewise, Hatta et al. (2014) found statistically significant reductions in the risk of 
developing delirium for the group receiving Ramelteon (p=0.002), along with slower time to 
development of 6.94 day vs. 5.74 days for the placebo group. Guo et al. (2015) found a 
reduced occurrence in delirium in the group receiving multicomponent nonpharmacological 
interventions (MNI) (10/81 (12%) vs 25/79 (31%)) as did Patel et al. (2014) (55/167 (33%) 
pre-intervention compared to 24/171 (14%) post-MNI). These were all statistically 
significant reductions in the overall incidence of delirium with P-values respectively p<0.003, 
p<0.006 and p<0.001.  MNI strategies included, for example, reduction of noise, use of eye 
shades and earplugs.  MNI bundles also reduced the duration of delirium with Patel et al. 
(2014) finding an average of 3.4 days of delirium pre-intervention to 1.2 days post (p=0.021) 
while Guo et al. (2015) reported an average of 28.1 hours in the MNI group vs. 60.2 hours in 
the control (p<0.001). 
Ono et al. (2011) and Taguchi et al. (2007)  demonstrated marked reductions in delirium 
occurrence in the groups receiving bright light therapy (BLT) (collectively 2/16 BLT vs. 10/17 
control). However, these results were not statistically significant due to limited sample sizes 
of 22 and 11 respectively, reducing the reliability of the results. In contrast, Simons et al. 
(2016) found a slight increase in the cumulative incidence of delirium in the patients 
receiving dynamic light application (DLA) 137/361 (38%) vs. 123/373 (33%) patients in the 
control group (OR 1.24, 95% CI 0.92-1.68, p=0.16). However, Simons et al. (2016) measured 
cumulative duration of delirium and coma free days and found a reduction of one day in the 
DLA group, however this was not statistically significant (p=0.29). Taguchi et al. (2007) also 
reported a reduction in the duration of symptoms of delirium following implementation of 
BLT, identifying that visual and auditory hallucinations stopped a day after BLT, whereas 
these symptoms persisted for several days in the control group. 
Circadian Rhythm: Arrhythmia and Entrainment 
To assess the efficacy of chronotherapy in maintenance of circadian rhythm, the circadian 
biomarkers of melatonin and cortisol were tested in two of the studies (Guo et al, 2015; 
Simons et al (2016).  Guo et al. (2015) found that while there were no significant differences 
in the neurohormone levels pre-operatively between the two study groups, postoperative 
nocturnal urine levels consistently showed statistically significant increases in melatonin and 
decreases in cortisol in the MNI group compared to the control group suggesting improved 
circadian rhythms with use of MNI. 
Conversely, Simons et al. (2016) assessed a subgroup of 20 patients (11 DLA vs. 9 control) 
and found no differences between the groups in the total excretion of the biomarkers when 
measured hourly during night-time or morning periods. Simons et al. (2016) also found that 
levels of melatonin did not vary significantly across the course of the day, suggesting 
abnormal secretion of melatonin and therefore circadian arrhythmia.  
Circadian rhythm was also measured through monitoring of physical and autonomic activity. 
Taguchi et al. (2007) showed reductions in physical activity on night four of the BLT 
intervention group, this was not significant in comparison to the control. Alternatively, Ono 
et al. (2011) conducted a time series of physical activity and found that the circadian cycle 
was 24.1 ± 3.2 hours for the BLT study group vs. 21.9 ± 1.5 hours for the control group, 
indicating BLT may assist with the entrainment of the circadian rhythm. Between the two 
groups however, no well-defined 24 hour periodicity of autonomic nervous system activity 
was found.  
Positive results from the MNI and BLT studies suggest that a combination of 
chronotherapeutic interventions may have more effect on the entrainment of circadian 
rhythm and reduce the prevalence of delirium, although the weight of the evidence is 
limited.  
Sleep Efficiency and Disturbance 
Sleep metrics, such as hours asleep and physical activity, were investigated in three of the 
studies. These studies used actigraphy (non invasive monitoring of activity and rest) and 
nurse assessment which can be inaccurate (Beecroft et al., 2008) rather than the gold-
standard polysomnography, which records biophysiological changes (such as muscle, brain 
and eye activity),  that occurs during sleep and offers more accurate sleep data . Patel et al. 
(2014) measured sleep quantity and quality using subjective measurements (patient 
reported sleep questionnaires and nursing assessments): with high compliance of the MNI 
bundle (>90%) the study showed significant reductions in night-time noise (p=0.002), light 
(p=0.003) and iatrogenic sleep disturbance (p=0.003). This led to a significant increase in 
mean hours of night-time sleep from 6.6 hours (55%) before the intervention vs. 8.6 hours 
(72%) after (p<0.001), and more windows of 3 hours uninterrupted sleep (32% before vs. 
39% after, p=0.029). Additionally, Patel et al. (2014) found that patients reporting high sleep 
efficiency index scores (length of time asleep vs length of time in bed) had a reduced risk of 
delirium with odds of developing delirium around 10% less (OR 0.90, 95% CI 0.84-0.97). 
However, this finding has limitations due to only 59/338 patients reporting sleep efficiency 
scores 
Using actigraphy, a significant reduction in physical activity was found on post-operative 
night 4 and 5 in patients receiving BLT (Ono et al, 2011). This suggests this group had greater 
night-time rest and deeper sleep. Sympathetic nervous activity was persistently reduced 
during the night compared to the control group especially at 2 am on night 5 (p<0.05).  
 Hatta et al. (2014) however did not find any benefit of Ramelteon on sleep efficiency based 
on sleep parameter measurements and no significant difference was found in the rate of 
Hydroxyzine use (for insomnia) between the group receiving Ramelteon and the control 
group. 
 Other Therapeutic Effects  
Other benefits of the chronotherapeutic interventions were found. During BLT, Ono et al. 
(2011) measured the occurrence of post-operative cardiac arrhythmias which were 
consistently lower in the intervention group with significant differences found on night 4 
and day 5 (p<0.05). Taguchi et al. (2007) found that ambulation started around 2 days 
earlier in the intervention group with a mean of 5.5 ± 1.0 days in comparison to 7.6 ± 2.5 
days in the control group, although this difference was not found to be statistically 
significant.  
As part of the MNI research, Guo et al. (2015) monitored the patients’ Richmond Agitation 
Sedation Score (RASS) twice daily and asked all patients to complete a 40 item quality of 
recovery score (QoR40). At each time interval measured for three days post-operatively the 
mean RASS scores were consistently lower in the intervention group (p<0.05). The QoR40 
score was also consistently higher (p<0.05) indicating a greater quality of recovery, taking 
into consideration emotional, physical and psychological factors.  
Discussion 
There is a large body of literature discussing the effects of circadian disruption and potential 
benefits of chronotherapy, but only a limited amount of primary research studying the 
effects of these interventions on delirium as a primary outcome within critical care. 
Following appraisal, mixed results for the efficacy of the chronotherapeutic interventions 
were found. 
Multicomponent Nonpharmacologic Interventions 
Both Patel et al. (2014) and Guo et al. (2015) explored the effectiveness of MNI (reduction in 
light and noise, use of eye shades, frequent patient orientation and provision of music) and 
found marked reductions in the incidence and duration of delirium. As delirium in critical 
care is associated with multiple adverse outcomes, this is a clinically significant finding 
(Girard et al., 2008; Bulic et al., 2015). Although non- critical care studies have shown that it 
is possible to reduce delirium prevalence through MNI (Inouye et al., 1999; Vidan et al., 
2009), the reviewed studies are the first to show the effect of MNI within critical care.  
The importance of increased staff education, awareness and understanding of delirium is a 
significant factor in the effectiveness of delirium intervention (O’Mahony et al., 2011). Patel 
et al. (2014) provided staff with ongoing training and information about sleep and delirium 
and reported a 90% compliance rate with the planned interventions which included 
substantially reducing night time noise and light levels as well as iatrogenic sleep 
disturbance. This significantly improved qualitative and quantitative sleep measures. 
Exogenous Melatonin and Melatonergic Agents 
The use of Ramelteon showed significant reductions in incidence, risk and frequency of 
delirium in acutely ill elderly patients even after controlling for risk factors (Hatta et al, 
2014). This indicates potential use of Ramelteon as a prophylactic treatment option for 
elderly patients at high risk of developing delirium. However, the generalisability of the 
results in view of the critical care population is substantially limited.  
Research studying the effects of exogenous melatonin is limited but has encouraging results. 
Three RCTs, which were conducted outside of a critical care setting, measured the effects of 
exogenous melatonin in acutely ill elderly patients and two studies found the incidence of 
delirium two to four times lower than in the control group (Sultan, 2010; Al-Aama et al., 
2011). The third study found no differences in the incidence of delirium, however 
significantly fewer patients receiving melatonin had a duration of delirium more than two 
days when compared to the control (26% vs. 47%, p=0.02) (de Jonghe et al., 2014)  
Melatonin has gained interest in critical care for its potential benefit as a physiological sleep 
aid due to its role in synchronisation of the circadian rhythm and sleep-wake pattern. Elliot 
et al. (2013) used polysomnography to assess sleep in critical care, finding an average total 
sleep time of 5 hours however, 41% of this was during day time hours indicating a diurnal 
shift of the sleep-wake cycle. The majority of sleep was also found to be in stages 1 (19%) 
and 2 (73%) with scant deeper, restorative phases of sleep. This indicates sleep quality is 
severely affected, leading to sleep deprivation which is associated with delirium, difficulty 
weaning, prolonged stay and increased mortality (Boyko et al., 2012). Of three studies which 
have looked at the effect of melatonin therapy to improve nocturnal sleep for critically ill 
patients, two found that melatonin improved sleep length and quality (Shilo et al., 2000; 
Bourne et al., 2008). The third study did not find any difference in observed nocturnal sleep 
(Ibrahim et al., 2006).           
Dynamic Light Application/ Bright Light Therapy 
The studies within this review that evaluated the use of light therapy had mixed results 
regarding the effect on the prevalence of delirium. Simons et al. (2016) carried out the most 
extensive study of DLA to date however, no differences were found in the incidence of 
delirium with only a 1-day reduction of delirium and coma-free days. The study design 
however had significant limitations and not all clinically important outcomes were measured 
such as sleep efficiency. Wilson (1972) found that twice as many episodes of delirium 
occurred in critical care areas without windows compared to those with windows suggesting 
that poor visible daylight contributes to the development of delirium; lack of visible daylight 
was also found by Van Rompaey et al. (2009) as being a significant risk factor for the 
development of delirium (OR 2.39, 95% CI 1.28-4.45, p=0.003).  
Both Ono et al. (2011) and Taguchi et al. (2007) used BLT of 5000 lux for 2 hours in the 
morning, which had the benefit of being closer to the subjective dawn, which has been 
shown to have a stronger circadian effect (Wirz-Justice et al., 2009).  Both studies 
demonstrated  favourable measures of sleep efficiency and marked deductions in the rates 
of delirium.  
While it is difficult to come to any conclusions for the efficacy of BLT or DLA in reducing the 
prevalence of delirium, a mixed methods study by Engwall et al. (2015) compared patients’ 
experiences of critical care rooms with different lighting environments. One had a cycled 
lighting system specially adapted to support patients’ circadian rhythm while the other used 
an ordinary lighting system. Results from the study showed significant differences in favour 
of the daytime brightness in intervention room (p=0.004) with patients describing the light 
as pleasant and healthy, with increased alertness and positive impacts on mood and feelings 
of security. This suggests important psychological benefits that light therapy may have in 
critical care, and may reduce the incidence of traumatic stressors associated with PTSD, 
including delirium (Vanderbilt University Medical Center, 2013).      
Recommendations 
The complex and multifactorial nature of delirium within critical care suggests that no single 
intervention is likely to be successful (Bourne and Mills, 2006). The use of MNI within critical 
care found consistently marked reductions in the prevalence of delirium. To enable the use 
of MNI within critical care, education of the multidisciplinary team a key factor. Guo et al. 
(2015) and Patel et al. (2014) identify that all critical care staff should have advanced 
training and education in order to implement MNI effectively with heightened awareness of 
delirium risk factors, correct assessment and treatment. Changes in clinical practice should 
also include reductions in iatrogenic sleep disturbance, modification of environmental noise 
and light and daily sedation targets (Patel et al., 2014; Guo et al., 2015; Madrid-Navarro et 
al., 2015). 
 
Although it is too early to recommend the use of melatonin or melatonergic agents as a 
prophylactic treatment of delirium, melatonin has been licensed in the UK for the short-
term treatment of insomnia in adults who are aged 55 and over (Bellapart and Boots, 2012; 
NICE, 2016). With significant chronotherapeutic benefits of improved sleep quality and 
latency, morning alertness and increased quality of life, this may also provide a clinically 
relevant alternative to conventional sedative-hypnotic agents currently being used in critical 
care (Lemoine and Zisapel, 2012; Huang et al., 2014). This is especially relevant for older 
patients in which use of conventional agents may adversely affect cognition, memory, sleep 
structure and increase their risk of delirium (Glass et al., 2005). 
 
While evidence is not strong enough to suggest BLT or DLA would be relevant in current 
practice to reduce the prevalence of delirium, all studies did agree that a natural bright 
lighting style is preferable in the critical care setting, and potential benefits were found 
regarding psychological well-being (Engwall et al., 2015). Application of real time monitoring 
of environmental variables (noise, light and temperature) may help to provide healthcare 
staff with accurate feedback necessary in order to promote circadian rhythms (Madrid-
Navarro et al., 2015).  
 
The identified chronotherapeutic interventions, in particular MNI interventions such as 
frequent patient orientation, enhancement of a ‘day night’ cycle in regards to noise and 
lighting, have promising results, however there is a clear need for large, multicentre RCTs 
which are well coordinated and measure all relevant physiologic outcomes of 
chronotherapy within the critical care setting. This should include delirium prevalence, 
sedation use  and sleep metrics (Logan and Sarkar, 2012; Oldham et al., 2016). Given the 
clinical benefits of restorative deep phases of sleep, further research should also look to use 
validated sleep assessments such as polysomnography in order to be able to gain an 
accurate measure of not only the quantity but also the quality of the sleep which has been 
linked to reductions in delirium (Weinhouse et al., 2009; Parthasarathy and Friese, 2012; 
Patel et al., 2014).  
 
Limitations 
The studies were undertaken globally and it is not clear how this may affect the 
epidemiology of delirium in the critical care setting as there is a paucity of data regarding 
the global prevalence of delirium (Salluh et al., 2010). However, it is important to 
acknowledge that differences in clinical practice may play a significant role in delirium 
prevalence and critical care outcomes (Beale et al., 2009; Patel et al., 2009). All identified 
studies had limitations regarding research design, control of confounding variables and 
lacked validated measures of important outcomes such as sleep. Between the different 
studies, a variety of different interventions were evaluated and different assessment tools 
were used; this inconsistency is a limitation to the review. 
 
Conclusion 
This review assessed whether chronotherapy can be used to reduce the prevalence of 
delirium in the critical care setting. Based on critical appraisal of the current research 
available, mixed results were found regarding the efficacy of the interventions. MNI showed 
greatest chronotherapeutic value for reduced delirium incidence, risk and duration. The 
melatonergic agent Ramelteon also showed promising results, significantly reducing 
incidence of delirium with less risk and frequency of occurrence. BLT and DLA studies 
obtained indeterminate results as no statistically significant differences regarding delirium 
prevalence were found.  
Based on these findings recommendations for practice include increasing the 
multidisciplinary team’s awareness of delirium through training and education, encouraging 
proactive review of medications, iatrogenic sleep disturbance and the critical care 
environment. Whilst more research is needed into the potential chronotherapeutic benefits 
of melatonin and light therapy and their effect on delirium, melatonin as a drug may provide 
a relevant alternative to sedative-hypnotics in older adults and increasing the light/dark 
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